Seres Therapeutics Inc (MCRB)

Precedente Chiudi:

$1.11

Aprire:

$1.11

Volume 24 ore:

4.43M

Capitalizzazione di mercato:

$175.17M

Reddito:

$126.33M

Utile/perdita netta:

$-113.72M

Rapporto P/E:

-0.9355

EPS:

-1.24

Flusso di cassa netto:

$-125.33M

1 W Prestazione:

+40.61%

1M Prestazione:

+59.87%

6M Prestazione:

-10.77%

1 anno Prestazione:

-77.78%

Intervallo 1D:

$1.08

$1.19

Portata 52W:

$0.54

$6.26

Seres Therapeutics Inc Stock (MCRB) Company Profile

Nome

Seres Therapeutics Inc

Settore

Healthcare (1213)

Industria

Biotechnology (699)

Telefono

617-945-9626

Indirizzo

200 Sidney Street, 4th Floor, Cambridge, MA

Dipendente

138

Cinguettio

@SeresTX

Prossima data di guadagno

2024-05-07

Ultimi documenti SEC

MCRB's Discussions on Twitter

Seres Therapeutics Inc Stock (MCRB) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-06-26	Ripresa	Oppenheimer	Outperform
2023-04-21	Iniziato	JP Morgan	Neutral
2021-07-23	Downgrade	Goldman	Neutral → Sell
2021-05-18	Ripresa	Goldman	Neutral
2021-03-05	Aggiornamento	Chardan Capital Markets	Neutral → Buy
2020-09-18	Downgrade	Chardan Capital Markets	Buy → Neutral
2020-08-18	Iniziato	Piper Sandler	Overweight
2020-08-11	Reiterato	H.C. Wainwright	Buy
2020-08-11	Aggiornamento	Jefferies	Hold → Buy
2019-04-30	Iniziato	Jefferies	Hold
2018-10-22	Iniziato	Chardan Capital Markets	Buy
2017-10-13	Iniziato	Oppenheimer	Outperform
2017-08-04	Reiterato	H.C. Wainwright	Buy
2017-02-01	Reiterato	FBR & Co.	Outperform
2016-08-12	Reiterato	FBR Capital	Outperform
2016-08-01	Downgrade	BofA/Merrill	Buy → Neutral
2016-08-01	Reiterato	H.C. Wainwright	Buy
2016-07-29	Ripresa	H.C. Wainwright	Buy
2016-03-30	Iniziato	FBR Capital	Outperform
2016-03-03	Iniziato	Guggenheim	Buy
2016-01-25	Iniziato	H.C. Wainwright	Buy
2015-10-22	Aggiornamento	BofA/Merrill	Neutral → Buy
2015-07-22	Iniziato	Canaccord Genuity	Buy
2015-07-21	Iniziato	Goldman	Neutral
2015-07-21	Iniziato	Leerink Partners	Outperform

Mostra tutto

Seres Therapeutics Inc Borsa (MCRB) Ultime notizie

Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday

Benzinga

Halozyme Therapeutics (HALO) Surges 5.6%: Is This an Indication of Further Gains?

Zacks Investment Research

Dow Tumbles Over 200 Points; US Trade Gap Narrows In November

Benzinga

Seres Therapeutics: Evaluating Vowst's Market Challenges (Rating Downgrade)

Seeking Alpha

Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Benzinga

Nasdaq Gains 1%; US Adds 150,000 Jobs In October

Benzinga

Seres Therapeutics Inc Azioni (MCRB) Dati Finanziari

Seres Therapeutics Inc (MCRB) Reddito 2024

Seres Therapeutics Inc (MCRB) Reddito netto 2024

Seres Therapeutics Inc (MCRB) Flusso di cassa 2024

Seres Therapeutics Inc (MCRB) Utile per azione 2024

Seres Therapeutics Inc Azioni (MCRB) insider trading